The U.S. Defense Health Agency has awarded a $1,195,789 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Regents of the University of California, San Francisco (UCSF) for the "SAFETY OF TRANSCUTANEOUS ELECTRICAL STIMULATION POTENTIATING RECOVERY IN ACUTE SPINAL CORD INJURY SYNDROMES (STEP-RAISE)" research project. The award, with a performance period from July 1, 2025 to June 30, 2028, will support UCSF's advanced biomedical research...
The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
The federal Project Grant award of $1,576,368 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) will fund an evaluation of electrical stimulation during nerve transfer surgery for cervical spinal cord injury at Stanford University. The grant, awarded on August 1, 2024, with a completion date of July 31, 2027, will support innovative research to develop advanced medical treatments for this condition. As a leading research institution,...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
The University of California, San Francisco (UCSF) has been awarded a $1,041,595 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from September 1, 2024 to August 31, 2027, will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The grant funding will enable UCSF to conduct innovative...
The federal Project Grant award of $860,998.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund advanced biomedical research focused on the "Neurophysiology of Post-Traumatic Epilepsy: Unraveling Epileptogenesis Signals Biomarkers" at the University of California, San Francisco (UCSF) from April 1, 2025 to March 31, 2028. UCSF, a prominent academic medical center and research...
The federal Project Grant award, ID HT94252410512, in the amount of $1,008,313.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader...
The U.S. Defense Health Agency awarded a $2,433,748 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, titled "DECISION SUPPORT TOOLS ADDRESSING TRAUMATIC BRAIN INJURY IN BRIDGE (STAT-BRIDGE)," is for the period of June 1, 2025 to May 31, 2029. The Project Grant supports UCSF's biomedical research focused on developing innovative decision support tools...
The Department of the Army Medical Command awarded a $774,196 Project Grant to the University of California, San Francisco through the Military Medical Research and Development program. The grant will fund research from July 2022 to July 2025 to discover prognostic biomarkers and drugs for neuropathic pain in chronic spinal cord injury using big data and machine learning approaches. The Military Medical Research and Development program aims to advance biomedical research that transforms military...
The Department of the Army Medical Command awarded a $2,377,839 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Regents of the University of California, San Francisco (UCSF) to conduct evidence-based research on predicting cardiovascular risk in immune-mediated inflammatory diseases. The grant, with a performance period from June 1, 2025 to May 31, 2029, supports UCSF's advanced biomedical research initiatives aimed at transforming...